Logo image of PSNL

PERSONALIS INC (PSNL) Stock Fundamental Analysis

NASDAQ:PSNL - Nasdaq - US71535D1063 - Common Stock - Currency: USD

6.58  +0.21 (+3.3%)

After market: 6.58 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PSNL. PSNL was compared to 55 industry peers in the Life Sciences Tools & Services industry. PSNL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PSNL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PSNL had negative earnings in the past year.
In the past year PSNL has reported a negative cash flow from operations.
PSNL had negative earnings in each of the past 5 years.
PSNL had a negative operating cash flow in each of the past 5 years.
PSNL Yearly Net Income VS EBIT VS OCF VS FCFPSNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

PSNL's Return On Assets of -30.76% is on the low side compared to the rest of the industry. PSNL is outperformed by 76.36% of its industry peers.
With a Return On Equity value of -40.54%, PSNL is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -30.76%
ROE -40.54%
ROIC N/A
ROA(3y)-38.97%
ROA(5y)-30.04%
ROE(3y)-58.56%
ROE(5y)-43.57%
ROIC(3y)N/A
ROIC(5y)N/A
PSNL Yearly ROA, ROE, ROICPSNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

PSNL has a Gross Margin of 33.30%. This is in the lower half of the industry: PSNL underperforms 70.91% of its industry peers.
PSNL's Gross Margin has been stable in the last couple of years.
PSNL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.05%
GM growth 5Y-1.31%
PSNL Yearly Profit, Operating, Gross MarginsPSNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

More info and screens

5

2. Health

2.1 Basic Checks

PSNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
PSNL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PSNL has been increased compared to 5 years ago.
Compared to 1 year ago, PSNL has an improved debt to assets ratio.
PSNL Yearly Shares OutstandingPSNL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PSNL Yearly Total Debt VS Total AssetsPSNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.67 indicates that PSNL is not a great score, but indicates only limited risk for bankruptcy at the moment.
PSNL has a Altman-Z score of 2.67. This is comparable to the rest of the industry: PSNL outperforms 58.18% of its industry peers.
PSNL has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.00, PSNL is doing good in the industry, outperforming 70.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.67
ROIC/WACCN/A
WACC10.1%
PSNL Yearly LT Debt VS Equity VS FCFPSNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

PSNL has a Current Ratio of 6.91. This indicates that PSNL is financially healthy and has no problem in meeting its short term obligations.
PSNL has a Current ratio of 6.91. This is amongst the best in the industry. PSNL outperforms 89.09% of its industry peers.
A Quick Ratio of 6.74 indicates that PSNL has no problem at all paying its short term obligations.
PSNL has a better Quick ratio (6.74) than 89.09% of its industry peers.
Industry RankSector Rank
Current Ratio 6.91
Quick Ratio 6.74
PSNL Yearly Current Assets VS Current LiabilitesPSNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.53% over the past year.
Looking at the last year, PSNL shows a quite strong growth in Revenue. The Revenue has grown by 15.57% in the last year.
The Revenue has been growing slightly by 5.35% on average over the past years.
EPS 1Y (TTM)27.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.77%
Revenue 1Y (TTM)15.57%
Revenue growth 3Y-0.34%
Revenue growth 5Y5.35%
Sales Q2Q%5.53%

3.2 Future

The Earnings Per Share is expected to grow by 15.04% on average over the next years. This is quite good.
Based on estimates for the next years, PSNL will show a very strong growth in Revenue. The Revenue will grow by 27.45% on average per year.
EPS Next Y29.55%
EPS Next 2Y14.51%
EPS Next 3Y12.06%
EPS Next 5Y15.04%
Revenue Next Year-0.29%
Revenue Next 2Y11.98%
Revenue Next 3Y15.84%
Revenue Next 5Y27.45%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PSNL Yearly Revenue VS EstimatesPSNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
PSNL Yearly EPS VS EstimatesPSNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PSNL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PSNL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSNL Price Earnings VS Forward Price EarningsPSNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSNL Per share dataPSNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PSNL's earnings are expected to grow with 12.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.51%
EPS Next 3Y12.06%

More info and screens

0

5. Dividend

5.1 Amount

PSNL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERSONALIS INC

NASDAQ:PSNL (6/27/2025, 8:00:00 PM)

After market: 6.58 0 (0%)

6.58

+0.21 (+3.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners42.82%
Inst Owner Change4.04%
Ins Owners1.18%
Ins Owner Change-0.04%
Market Cap581.21M
Analysts82.86
Price Target7.4 (12.46%)
Short Float %6.74%
Short Ratio5.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.74%
Min EPS beat(2)20.88%
Max EPS beat(2)28.59%
EPS beat(4)3
Avg EPS beat(4)1.79%
Min EPS beat(4)-79.27%
Max EPS beat(4)36.97%
EPS beat(8)6
Avg EPS beat(8)7.11%
EPS beat(12)8
Avg EPS beat(12)5.88%
EPS beat(16)11
Avg EPS beat(16)6.02%
Revenue beat(2)2
Avg Revenue beat(2)10.33%
Min Revenue beat(2)4.66%
Max Revenue beat(2)15.99%
Revenue beat(4)4
Avg Revenue beat(4)13.44%
Min Revenue beat(4)4.66%
Max Revenue beat(4)18.2%
Revenue beat(8)6
Avg Revenue beat(8)7.55%
Revenue beat(12)10
Avg Revenue beat(12)8%
Revenue beat(16)12
Avg Revenue beat(16)6.03%
PT rev (1m)-1.14%
PT rev (3m)-2.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.03%
EPS NY rev (1m)-0.21%
EPS NY rev (3m)12.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.85%
Revenue NY rev (1m)-0.7%
Revenue NY rev (3m)0.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.78
P/FCF N/A
P/OCF N/A
P/B 2.8
P/tB 2.8
EV/EBITDA N/A
EPS(TTM)-1.29
EYN/A
EPS(NY)-0.94
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0.97
BVpS2.35
TBVpS2.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.76%
ROE -40.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.3%
FCFM N/A
ROA(3y)-38.97%
ROA(5y)-30.04%
ROE(3y)-58.56%
ROE(5y)-43.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.05%
GM growth 5Y-1.31%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 37.51%
Cap/Sales 4.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.91
Quick Ratio 6.74
Altman-Z 2.67
F-Score5
WACC10.1%
ROIC/WACCN/A
Cap/Depr(3y)234.39%
Cap/Depr(5y)188.79%
Cap/Sales(3y)31.15%
Cap/Sales(5y)22.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.77%
EPS Next Y29.55%
EPS Next 2Y14.51%
EPS Next 3Y12.06%
EPS Next 5Y15.04%
Revenue 1Y (TTM)15.57%
Revenue growth 3Y-0.34%
Revenue growth 5Y5.35%
Sales Q2Q%5.53%
Revenue Next Year-0.29%
Revenue Next 2Y11.98%
Revenue Next 3Y15.84%
Revenue Next 5Y27.45%
EBIT growth 1Y24.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14.2%
EBIT Next 3Y-0.12%
EBIT Next 5Y19.61%
FCF growth 1Y60.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.78%
OCF growth 3YN/A
OCF growth 5YN/A